Mental Wellness Program
Bio-Venlafaxine XR venlafaxine
Evaluated tools to help you understand your treatment, track what changes and know who to talk to.
Coming soon: this product is not marketed yet.
Where are you in your treatment?
-
Weeks 1–2
Getting started
-
Weeks 2–6
Feeling the first effects
-
6 weeks and more
Staying on track
-
Any time
Something feels off
Essentials to get started
-
App
Daylio
Mood journal: log how you feel and what you did, then spot patterns. Handy to bring to your appointments.
-
Article
Understanding antidepressant medications, part 1: how to use them safely
What antidepressants do, how long they take to work, and which side effects are common at the start.
-
Website
MesOutils.ca
Free Quebec platform: journal, exercises, questionnaires and a safety plan to get through difficult times.
-
Website
Bounce Back
Guided self-help program: phone coaching, practical workbooks and short videos to manage low mood, stress and anxiety.
-
App
Prezens
Short breathing, meditation and mindfulness exercises to pause and find calm.
Tools by topic
Understand your treatment
How venlafaxine works, and what to expect.
-
Article
Understanding antidepressant medications, part 1: how to use them safely
What antidepressants do, how long they take to work, and which side effects are common at the start.
-
Article
Antidepressants, part 2: when and how to stop
When stopping may be considered, how to taper gradually with a professional, and which withdrawal symptoms to watch for.
-
Article
Drugs for treatment of depression
Consumer reference on antidepressant classes, how they act, and their side effects.
-
Podcast
One in Five, with Florence K — Episode 6: Depressive disorders
An artist's first-hand account of depression, her daughter's perspective, and a psychologist's advice for people affected and their loved ones.
-
Video
The black dog of depression
Short WHO animation that portrays depression as a "black dog" and shows that it can be tamed.
Take care of yourself day to day
Therapy, stress management and support, at your own pace.
-
Website
Relief — self-management workshops
10- to 12-week group workshops, online or in person in several Quebec regions, to live better with anxiety, depression or bipolar disorder.
-
Website
Bounce Back
Guided self-help program: phone coaching, practical workbooks and short videos to manage low mood, stress and anxiety.
-
Video
Building connections and being well surrounded
Why social connections protect mental health, with practical ideas to build and keep them.
-
App
Prezens
Short breathing, meditation and mindfulness exercises to pause and find calm.
-
App
MindDay
Daily online coaching based on recognized strategies and mindfulness, to better understand thoughts and emotions.
-
Website
Équilia — CBT and mindfulness program
Free, self-paced 6-lesson online program combining cognitive behavioural therapy and mindfulness. No waiting list.
Track what changes
Note how you feel to see how things evolve, and bring it to your appointments.
-
App
Daylio
Mood journal: log how you feel and what you did, then spot patterns. Handy to bring to your appointments.
-
Website
MesOutils.ca
Free Quebec platform: journal, exercises, questionnaires and a safety plan to get through difficult times.
Know when to call
What is expected, what should make you call, and who to contact.
-
Article
Understanding antidepressant medications, part 1: how to use them safely
What antidepressants do, how long they take to work, and which side effects are common at the start.
-
Article
Drugs for treatment of depression
Consumer reference on antidepressant classes, how they act, and their side effects.
-
Website
MesOutils.ca
Free Quebec platform: journal, exercises, questionnaires and a safety plan to get through difficult times.
Bio-Venlafaxine XR products
Other venlafaxine DINs on the market 54
54 products from other manufacturers. If your DIN is in this list, the tools on this page apply to you too.
| DIN | Brand | Manufacturer | Strength | Form | DPD status |
|---|---|---|---|---|---|
| 02331683 | APO-VENLAFAXINE XR | APOTEX INC | 37.5 mg | CAPSULE (EXTENDED-RELEASE) | Dormant (not currently sold) |
| 02331691 | APO-VENLAFAXINE XR | APOTEX INC | 75 mg | CAPSULE (EXTENDED-RELEASE) | Dormant (not currently sold) |
| 02331705 | APO-VENLAFAXINE XR | APOTEX INC | 150 mg | CAPSULE (EXTENDED-RELEASE) | Dormant (not currently sold) |
| 02452839 | AURO-VENLAFAXINE XR | AURO PHARMA INC | 37.5 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02452847 | AURO-VENLAFAXINE XR | AURO PHARMA INC | 75 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02452855 | AURO-VENLAFAXINE XR | AURO PHARMA INC | 150 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02237279 | EFFEXOR XR | BGP PHARMA ULC | 37.5 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02237280 | EFFEXOR XR | BGP PHARMA ULC | 75 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02237282 | EFFEXOR XR | BGP PHARMA ULC | 150 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02516535 | VENLAFAXINE XR | JAMP PHARMA CORPORATION | 37.5 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02516543 | VENLAFAXINE XR | JAMP PHARMA CORPORATION | 75 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02516551 | VENLAFAXINE XR | JAMP PHARMA CORPORATION | 150 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02489678 | VENLAFAXINE XR | LABORATOIRE RIVA INC. | 37.5 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02489686 | VENLAFAXINE XR | LABORATOIRE RIVA INC. | 75 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02489694 | VENLAFAXINE XR | LABORATOIRE RIVA INC. | 150 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02471280 | M-VENLAFAXINE XR | MANTRA PHARMA INC | 37.5 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02471299 | M-VENLAFAXINE XR | MANTRA PHARMA INC | 75 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02471302 | M-VENLAFAXINE XR | MANTRA PHARMA INC | 150 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02560259 | MAR-VENLAFAXINE XR | MARCAN PHARMACEUTICALS INC | 37.5 mg | CAPSULE (EXTENDED-RELEASE) | Approved, not yet marketed |
| 02560267 | MAR-VENLAFAXINE XR | MARCAN PHARMACEUTICALS INC | 75 mg | CAPSULE (EXTENDED-RELEASE) | Approved, not yet marketed |
| 02560275 | MAR-VENLAFAXINE XR | MARCAN PHARMACEUTICALS INC | 150 mg | CAPSULE (EXTENDED-RELEASE) | Approved, not yet marketed |
| 02522977 | MINT-VENLAFAXINE XR | MINT PHARMACEUTICALS INC | 37.5 mg | CAPSULE (EXTENDED-RELEASE) | Dormant (not currently sold) |
| 02522985 | MINT-VENLAFAXINE XR | MINT PHARMACEUTICALS INC | 75 mg | CAPSULE (EXTENDED-RELEASE) | Dormant (not currently sold) |
| 02522993 | MINT-VENLAFAXINE XR | MINT PHARMACEUTICALS INC | 150 mg | CAPSULE (EXTENDED-RELEASE) | Dormant (not currently sold) |
| 02565544 | NRA-VENLAFAXINE XR | NORA PHARMA INC | 37.5 mg | CAPSULE (EXTENDED-RELEASE) | Approved, not yet marketed |
| 02565552 | NRA-VENLAFAXINE XR | NORA PHARMA INC | 75 mg | CAPSULE (EXTENDED-RELEASE) | Approved, not yet marketed |
| 02565560 | NRA-VENLAFAXINE XR | NORA PHARMA INC | 150 mg | CAPSULE (EXTENDED-RELEASE) | Approved, not yet marketed |
| 02278545 | PMS-VENLAFAXINE XR | PHARMASCIENCE INC | 37.5 mg | CAPSULE (EXTENDED-RELEASE) | Dormant (not currently sold) |
| 02521466 | PMSC-VENLAFAXINE XR | PHARMASCIENCE INC | 37.5 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02278553 | PMS-VENLAFAXINE XR | PHARMASCIENCE INC | 75 mg | CAPSULE (EXTENDED-RELEASE) | Dormant (not currently sold) |
| 02521482 | PMSC-VENLAFAXINE XR | PHARMASCIENCE INC | 75 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02278561 | PMS-VENLAFAXINE XR | PHARMASCIENCE INC | 150 mg | CAPSULE (EXTENDED-RELEASE) | Dormant (not currently sold) |
| 02521474 | PMSC-VENLAFAXINE XR | PHARMASCIENCE INC | 150 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02339242 | VENLAFAXINE XR | PRO DOC LIMITEE | 37.5 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02339250 | VENLAFAXINE XR | PRO DOC LIMITEE | 75 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02339269 | VENLAFAXINE XR | PRO DOC LIMITEE | 150 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02310317 | SANDOZ VENLAFAXINE XR | SANDOZ CANADA INCORPORATED | 37.5 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02310325 | SANDOZ VENLAFAXINE XR | SANDOZ CANADA INCORPORATED | 75 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02310333 | SANDOZ VENLAFAXINE XR | SANDOZ CANADA INCORPORATED | 150 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02354713 | VENLAFAXINE XR | SANIS HEALTH INC | 37.5 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02354721 | VENLAFAXINE XR | SANIS HEALTH INC | 75 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02354748 | VENLAFAXINE XR | SANIS HEALTH INC | 150 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02385929 | VENLAFAXINE XR | SIVEM PHARMACEUTICALS ULC | 37.5 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02385937 | VENLAFAXINE XR | SIVEM PHARMACEUTICALS ULC | 75 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02385945 | VENLAFAXINE XR | SIVEM PHARMACEUTICALS ULC | 150 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02380072 | TARO-VENLAFAXINE XR | SUN PHARMA CANADA INC | 37.5 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02380080 | TARO-VENLAFAXINE XR | SUN PHARMA CANADA INC | 75 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02380099 | TARO-VENLAFAXINE XR | SUN PHARMA CANADA INC | 150 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02275023 | TEVA-VENLAFAXINE XR | TEVA CANADA LIMITED | 37.5 mg | CAPSULE (EXTENDED-RELEASE) | Dormant (not currently sold) |
| 02304317 | ACT VENLAFAXINE XR | TEVA CANADA LIMITED | 37.5 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02275031 | TEVA-VENLAFAXINE XR | TEVA CANADA LIMITED | 75 mg | CAPSULE (EXTENDED-RELEASE) | Dormant (not currently sold) |
| 02304325 | ACT VENLAFAXINE XR | TEVA CANADA LIMITED | 75 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
| 02275058 | TEVA-VENLAFAXINE XR | TEVA CANADA LIMITED | 150 mg | CAPSULE (EXTENDED-RELEASE) | Dormant (not currently sold) |
| 02304333 | ACT VENLAFAXINE XR | TEVA CANADA LIMITED | 150 mg | CAPSULE (EXTENDED-RELEASE) | Marketed |
For pharmacists and healthcare professionals
Every tool was evaluated against public criteria. You can share this page directly with your patients: no DIN is required.